Back to Search Start Over

The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century

The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century

Authors :
John Paget
Olga Bessonova
Joseph S. Bresee
Norosoa Harline Razanajatovo
Saverio Caini
Binay Thapa
Francisco José de Paula Júnior
Jenny Lara Araya
Florette K. Treurnicht
Walquiria Aparecida Ferreira de Almeida
Brechla Moreno Arévalo
Zhibin Peng
Raquel Guiomar
Gabriela Kusznierz
Q. Sue Huang
Herman Kosasih
Antonino Bella
Doménica de Mora
Rakhee Palekar
Olha Holubka
Maria R. Castrucci
Rudevelinda Rivera
Phuong Vu Mai Hoang
Gideon O. Emukule
Rodrigo Fasce
Rocio Higueros
Sandra S. Chaves
Fatima el Falaki
Mai T. Q. Le
Herve A. Kadjo
Patricia Bustos
Luzhao Feng
Ainash Makusheva
Vernon J. Lee
Richard Njouom
Ana Paula Rodrigues
Coulibaly Daouda
Gé Donker
Alfredo Bruno
Alla Mironenko
Cheryl Cohen
Jean-Michel Heraud
Li Wei Ang
Sonam Wangchuk
Mónica Jeannette Barahona de Gámez
Maria Zambon
Clotilde El Guerche-Séblain
Angel Balmaseda
Lynnette Brammer
Amal Barakat
Richard Pebody
Adam Meijer
Verònica Vera Garate
Tim Wood
Netherlands Institute for Health Services Research [Utrecht] (NIVEL)
Instituto Nacional de Enfermedades Respiratorias Dr. Emilio Coni [Santa Fe, Argentina] (INER)
Ministry of Health [Bhoutan]
Ministry of Health [Brasília, Brazil]
Centre Pasteur du Cameroun
Réseau International des Instituts Pasteur (RIIP)
Instituto de Salud Pública de Chile (ISP)
Chinese Center for Disease Control and Prevention
Ministry of Health [Costa Rica]
Instituto Nacional de Investigación en Salud Pública [Guayaquil, Ecuador] (INSPI)
Ministerio de Salud de El Salvador (MINSAL)
Public Health England [London]
Ministerio de Salud Publica y Asistencia Social [Guatemala] (MSPAS)
Ministry of Health [Honduras] (SESAL)
US Naval Medical Research Unit No.2 [Jakarta, Indonesia] (NAMRU-2)
Naval Medical Research Center [Silver Spring, USA] (NMRC)
Istituto Superiore di Sanita [Rome]
Institut Pasteur de Côte d'Ivoire
Institut National de Santé Publique d'Abidjan-INSP
Ministry of Healthcare [Kazakhstan]
Centers for Disease Control and Prevention [Atlanta] (CDC)
Centers for Disease Control and Prevention
Centers for Disease Control and Prevention [Kenya]
Unité de Virologie [Antananarivo, Madagascar] (IPM)
Institut Pasteur de Madagascar
Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)
Institut National d'Hygiène [Maroc]
National Institute for Public Health and the Environment [Bilthoven] (RIVM)
Institute of Environmental Science and Research (ESR)
Ministry of Health [Nicaragua] (MINSA)
Pan American Health Organization [Washington] (PAHO)
Instituto Conmemorativo Gorgas de Estudios de la Salud [Panamá]
Instituto Nacional de Saùde Dr Ricardo Jorge [Portugal] (INSA)
Ministry of Health [Singapore]
National Institute for Communicable Diseases [Johannesburg] (NICD)
University of the Witwatersrand [Johannesburg] (WITS)
National Academy of Sciences of Ukraine (NASU)
National Institute of Hygiene and Epidemiology [Hanoi, Vietnam] (NIHE)
Sanofi Pasteur [Lyon, France]
The study is supported by a research grant from Sanofi Pasteur: the ‘Global Epidemiology of Influenza B’ research project. The funder provided support in the form of salaries for two authors (CEGS and JP) but did not have any additional role in the data collection, analysis, decision to publish, or preparation of the manuscript.
The 'Global Influenza B Study team' (group authorship) includes the following scientists: Juan Manuel Rudi (jmrudi@anlis.gov.ar), National Institute of Respiratory Diseases 'Emilio Coni', Santa Fe, Argentina
Dorji Wangchuk (dorjiwangchuk@health.gov.bt) and Sangay Zangmo (szangmo@health.gov.bt), Royal Centre for Disease Control, Department of Public Health, Ministry of Health, Thimphu, Bhutan
Daiana Araujo da Silva (daiana.silva@saude.gov.br), Ministry of Health, Department of Surveillance of Transmissible Diseases, Brasília/DF, Brazil
Winston Andrade (wandrade@ispch.cl), Sub-Department of Viral Diseases, Instituto de Salud Pública de Chile, Santiago, Chile
Jiandong Zheng (zhengjd@chinacdc.cn) and Ying Qin (qinying@chinacdc.cn), Division of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, P.R. China
Joanna Ellis (joanna.ellis@phe.gov.uk), Public Health England, London, United Kingdom
Simona Puzelli (simona.puzelli@iss.it), National Influenza Center, Department of Infectious Diseases, National Institute of Health, Rome, Italy
Caterina Rizzo (rizzocaterina@gmail.com), Bambino Gesù Children's Hospital, Rome, Italy
Linus Ndegwa (ikf7@cdc.gov), Influenza Program, Centers for Disease Control and Prevention, Nairobi, Kenya
Marit MA de Lange (marit.de.lange@rivm.nl) and Anne C. Teirlinck (anne.teirlinck@rivm.nl), National Institute for Public Health and the Environment, Centre for Infectious Diseases, Epidemiology and Surveillance, Bilthoven, The Netherlands
Jeffery Cutter (jeffery_cutter@moh.gov.sg) and Raymond Tzer Pin Lin (raymond_lin@moh.gov.sg), Public Health Group, Ministry of Health, Singapore, Singapore
Than T. Le (lmot82@yahoo.com), National Institute of Hygiene and Epidemiology, Hanoi, Vietnam
Peter Kinuthia 42 (polorien@gmail.com), IHRC Inc., Atlanta, USA.
Source :
PLoS ONE, PLoS ONE, Public Library of Science, 2019, 14 (9), pp.e0222381. ⟨10.1371/journal.pone.0222381⟩, PLoS ONE, Vol 14, Iss 9, p e0222381 (2019)
Publication Year :
2019
Publisher :
Public Library of Science (PLoS), 2019.

Abstract

Free PMC article: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31513690/ We describe the epidemiological characteristics, pattern of circulation, and geographical distribution of influenza B viruses and its lineages using data from the Global Influenza B Study. We included over 1.8 million influenza cases occurred in thirty-one countries during 2000-2018. We calculated the proportion of cases caused by influenza B and its lineages; determined the timing of influenza A and B epidemics; compared the age distribution of B/Victoria and B/Yamagata cases; and evaluated the frequency of lineage-level mismatch for the trivalent vaccine. The median proportion of influenza cases caused by influenza B virus was 23.4%, with a tendency (borderline statistical significance, p = 0.060) to be higher in tropical vs. temperate countries. Influenza B was the dominant virus type in about one every seven seasons. In temperate countries, influenza B epidemics occurred on average three weeks later than influenza A epidemics; no consistent pattern emerged in the tropics. The two B lineages caused a comparable proportion of influenza B cases globally, however the B/Yamagata was more frequent in temperate countries, and the B/Victoria in the tropics (p = 0.048). B/Yamagata patients were significantly older than B/Victoria patients in almost all countries. A lineage-level vaccine mismatch was observed in over 40% of seasons in temperate countries and in 30% of seasons in the tropics. The type B virus caused a substantial proportion of influenza infections globally in the 21st century, and its two virus lineages differed in terms of age and geographical distribution of patients. These findings will help inform health policy decisions aiming to reduce disease burden associated with seasonal influenza. info:eu-repo/semantics/publishedVersion

Subjects

Subjects :
RNA viruses
Male
Infecções Respiratórias
0301 basic medicine
Viral Diseases
medicine.disease_cause
MESH: Influenza Vaccines
Seasonal influenza
Influenza A Virus, H1N1 Subtype
0302 clinical medicine
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Epidemiology
Medicine and Health Sciences
Influenza A virus
030212 general & internal medicine
MESH: Influenza B virus
Pathology and laboratory medicine
Northern Hemisphere
Vaccines
[SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases
Multidisciplinary
Geography
MESH: Influenza, Human
virus diseases
Medical microbiology
3. Good health
Infectious Diseases
Influenza Vaccines
Population Surveillance
Viruses
Epidemiological Monitoring
[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology
Medicine
Southern Hemisphere
Female
Age distribution
Seasons
Pathogens
MESH: History, 21st Century
Research Article
medicine.medical_specialty
Infectious Disease Control
Science
MESH: Influenza A virus
Biology
Microbiology
History, 21st Century
Virus
MESH: Population Surveillance
MESH: Influenza A Virus, H1N1 Subtype
03 medical and health sciences
Age Distribution
Population Metrics
Influenza, Human
medicine
Influenza viruses
Humans
Epidemics
MESH: Epidemics
Disease burden
MESH: Humans
Biology and life sciences
Population Biology
Organisms
Viral pathogens
[SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology
Estados de Saúde e de Doença
Virology
Influenza
MESH: Male
Microbial pathogens
Earth sciences
Influenza B virus
Vaccine mismatch
030104 developmental biology
Virus type
[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
MESH: Epidemiological Monitoring
Geographic areas
MESH: Seasons
MESH: Female
Orthomyxoviruses

Details

ISSN :
19326203
Volume :
14
Database :
OpenAIRE
Journal :
PLOS ONE
Accession number :
edsair.doi.dedup.....b8a3767cba09b9831f884769bcd4bad7
Full Text :
https://doi.org/10.1371/journal.pone.0222381